Evidence map›Paper›PMID 33614905›Full record

ReviewAdvanced therapeutics2021

Management of Coronavirus Disease 2019 (COVID-19) Pandemic: From Diagnosis to Treatment Strategies.

Zhina Hadisi, Tavia Walsh, Seyed Mohammad Hossein Dabiri, Amir Seyfoori, David Hamdi, Bahram Mirani, Erik Pagan, Armando Jardim, Mohsen Akbari

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Advanced therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Zhina HadisiLaboratory for Innovation in Microengineering (LiME), Department of Mechanical Engineering, Center for Biomedical Research University of Victoria 3800 Finnerty Rd. Victoria BC V8P 2C5 Canada.
Tavia WalshLaboratory for Innovation in Microengineering (LiME), Department of Mechanical Engineering, Center for Biomedical Research University of Victoria 3800 Finnerty Rd. Victoria BC V8P 2C5 Canada.
Seyed Mohammad Hossein DabiriLaboratory for Innovation in Microengineering (LiME), Department of Mechanical Engineering, Center for Biomedical Research University of Victoria 3800 Finnerty Rd. Victoria BC V8P 2C5 Canada.
Amir SeyfooriLaboratory for Innovation in Microengineering (LiME), Department of Mechanical Engineering, Center for Biomedical Research University of Victoria 3800 Finnerty Rd. Victoria BC V8P 2C5 Canada.
David HamdiLaboratory for Innovation in Microengineering (LiME), Department of Mechanical Engineering, Center for Biomedical Research University of Victoria 3800 Finnerty Rd. Victoria BC V8P 2C5 Canada.
Bahram MiraniDepartment of Mechanical and Industrial Engineering University of Toronto Toronto ON M5S 3G8 Canada.
Erik PaganLaboratory for Innovation in Microengineering (LiME), Department of Mechanical Engineering, Center for Biomedical Research University of Victoria 3800 Finnerty Rd. Victoria BC V8P 2C5 Canada.
Armando JardimLaboratory for Innovation in Microengineering (LiME), Department of Mechanical Engineering, Center for Biomedical Research University of Victoria 3800 Finnerty Rd. Victoria BC V8P 2C5 Canada.
Mohsen AkbariLaboratory for Innovation in Microengineering (LiME), Department of Mechanical Engineering, Center for Biomedical Research University of Victoria 3800 Finnerty Rd. Victoria BC V8P 2C5 Canada.ORCID https://orcid.org/0000-0003-2902-6557
University of Victoria · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the emergence of severe acute respiratory syndrome (SARS) in 2002 and the Middle East respiratory syndrome (MERS) in 2012, the world is now combating a third large-scale outbreak caused by a coronavirus, the coronavirus disease 2019 (COVID-19). After the rapid spread of SARS-coronavirus (CoV)-2 (the virus causing COVID-19) from its origin in China, the World Health Organization (WHO) declared a Public Health Emergency of International Concern (PHEIC) on January 30, 2020. From the beginning of the COVID-19 pandemic, a significant number of studies have been conducted to better understand the biology and pathogenesis of the novel coronavirus, and to aid in developing effective treatment regimens, therapeutics, and vaccines. This review focuses on the recent advancements in the rapidly evolving areas of clinical care and management of COVID-19. The emerging strategies for the diagnosis and treatment of this disease are explored, and the development of effective vaccines is reviewed.

Indexed as

coronavirus disease 2019COVID 19MERSSARStreatment strategies

Identifiers

PMID33614905
PMCPMC7883285
OpenAlexW3111732475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.